OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 03:35:56 2024-07-05 pm EDT | ||
| 0.54 EUR | +3.85% |
|
| Current month | -3.57% | ||
| 1 month | +3.85% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 0.54 | +3.85% |
| 24-07-04 | 0.52 | -1.89% |
| 24-07-03 | 0.53 | -3.64% |
| 24-07-02 | 0.55 | 0.00% |
| 24-07-01 | 0.55 | -1.79% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 03:35 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HS133J |
| ISIN | DE000HS133J2 |
| Date issued | 2023-08-08 |
| Strike | 253 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.75 € |
|---|---|
| Lowest since issue | 0.09 € |
| Spread | 0.03 € |
| Spread % | 5.26% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Certificates
- Certificat
